\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ palpable\\ abnormality\\ in\\ region\\ of\\ left\\ scapula\\;\\ physical\\ exam\\ was\\ unrevealing\\.\ \(0\)\
\-\ further\\ investigation\\ of\\ the\\ patient\\â\\€\\™s\\ cardiac\\ history\\ revealed\\ that\\ he\\ had\\ sustained\\ a\\ left\\ ventricle\\ inferobasilar\\ wall\\ myocardial\\ infarction\\ \\(mi\\)\\ four\\ years\\ earlier\\ \\(occluded\\ left\\ circumflex\\ coronary\\ artery\\)\\.\\ \\ prior\\ echocardiography\\ exams\\ noted\\ moderate\\ aortic\\ stenosis\\ as\\ well\\ as\\ a\\ severely\\ hypokinetic\\ inferobasilar\\ lv\\ wall\\ related\\ to\\ the\\ history\\ of\\ mi\\.\ \(0\)\
\-\ as\\ the\\ patient\\ had\\ also\\ been\\ noticing\\ a\\ recent\\ increase\\ in\\ bilateral\\ leg\\ swelling\\,\\ an\\ echocardiogram\\ was\\ repeated\\.\\ \\ the\\ exam\\ demonstrated\\ persisting\\ severe\\ hypokinesis\\ of\\ the\\ inferobasilar\\ wall\\ with\\ mild\\ generalized\\ lv\\ diastolic\\ dysfunction\\.\\ \\ moderate\\ aortic\\ stenosis\\ \\(valve\\ area\\ 0\\.9cm2\\)\\ with\\ bicuspid\\ aortic\\ valve\\ and\\ mild\\ lv\\ hypertrophy\\ was\\ unchanged\\.\ \(0\)\
\-\ anterior\\ and\\ posterior\\ planar\\ images\\ of\\ the\\ chest\\ from\\ a\\ nuclear\\ medicine\\ bone\\ scan\\ \\(obtained\\ 2\\ hours\\ after\\ injection\\ of\\ technitium\\-99m\\ hdp\\)\\ demonstrate\\ abnormal\\ radiopharmaceutical\\ accumulation\\ within\\ the\\ left\\ ventricular\\ walls\\ of\\ the\\ heart\\.\\ \\ \ \(0\)\
\-\ posterior\\-anterior\\ chest\\ radiograph\\ and\\ contrast\\-enhanced\\ cardiac\\ computed\\ tomography\\ \\(ct\\)\\ demonstrate\\ curvilinear\\ subendocardial\\ calcification\\ in\\ the\\ inferobasilar\\ wall\\ of\\ the\\ heart\\.\\ \\ a\\ metallic\\ pacemaker\\ wire\\ is\\ in\\ place\\ with\\ tip\\ projecting\\ in\\ the\\ expected\\ location\\ of\\ the\\ right\\ ventricle\\.\ \(0\)\
\-\ calcifying\\ myocardium\\ from\\ previous\\ infarction\ \(0\)\
\-\ \\â\\€\\¢\\ heart\\ attack\\ \\(myocardial\\ ischemia\\ \\/\\ necrosis\\)\ \(0\)\
\-\ \\â\\€\\¢\\ mediastinal\\ mass\\ \\(eg\\.\\ malignancy\\)\ \(0\)\
\-\ this\\ 78\\ y\\.o\\.\\ man\\ presented\\ with\\ left\\ scapular\\ pain\\.\\ \\ he\\ has\\ a\\ history\\ of\\ smoking\\ \\(100\\+\\ pack\\-yrs\\)\\;\\ and\\,\\ a\\ history\\ of\\ prostate\\ cancer\\ treated\\ with\\ localized\\ radiotherapy\\.\ \(0\)\
\-\ detecting\\ and\\ recognizing\\ calcification\\ related\\ to\\ the\\ heart\\ on\\ nuclear\\ medicine\\ bone\\ scans\\ and\\ other\\ imaging\\ modalities\\ may\\ have\\ important\\ clinical\\ implications\\.\\ \\ for\\ example\\,\\ the\\ amount\\ of\\ coronary\\ artery\\ calcification\\ correlates\\ with\\ the\\ severity\\ of\\ coronary\\ artery\\ disease\\ \\(cad\\)\\,\\ and\\ calcification\\ of\\ the\\ aortic\\ or\\ mitral\\ valve\\ may\\ indicate\\ hemodynamically\\ significant\\ valvular\\ stenosis\\.\ \(0\)\
\-\ this\\ case\\ demonstrates\\ the\\ classic\\ finding\\ of\\ myocardial\\ calcium\\ deposition\\ from\\ prior\\ mi\\.\\ \\ approximately\\ 8\\%\\ of\\ patients\\ who\\ sustain\\ a\\ large\\ myocardial\\ infarction\\ develop\\ myocardial\\ calcification\\,\\ with\\ anterolateral\\ wall\\ lv\\ infarcts\\ most\\ commonly\\ seen\\ in\\ association\\ with\\ lv\\ aneurysm\\.\ \(0\)\
\-\ other\\ causes\\ for\\ calcification\\ within\\ the\\ walls\\ of\\ the\\ heart\\ may\\ include\\ myocarditis\\ and\\ amyloid\\ deposition\\.\\ soft\\ tissue\\ calcium\\ deposition\\ can\\ be\\ seen\\ in\\ a\\ wide\\ variety\\ of\\ disease\\ processes\\ \\(inflammation\\,\\ infarction\\ and\\ necrosis\\,\\ metastatic\\ calcification\\ in\\ renal\\ failure\\,\\ and\\ hypercalcemia\\ of\\ any\\ cause\\)\\;\\ however\\,\\ the\\ exact\\ mechanism\\ for\\ cardiac\\ activity\\ as\\ seen\\ on\\ nuclear\\ medicine\\ bone\\ scans\\ is\\ debated\\,\\ and\\ the\\ degree\\ of\\ cardiac\\ activity\\ on\\ bone\\ scan\\ may\\ differ\\ from\\ visualized\\ calcification\\ on\\ ct\\ imaging\\.\ \(0\)\
\-\ localizing\\ calcification\\ to\\ the\\ walls\\ of\\ the\\ heart\\ versus\\ within\\ the\\ pericardium\\ is\\ important\\ as\\ pericardial\\ calcification\\ is\\ strongly\\ associated\\ with\\ constrictive\\ pericarditis\\.\\ \\ \ \(0\)\
\-\ in\\ summary\\,\\ correct\\ assessment\\ of\\ cardiac\\ calcification\\ location\\ is\\ important\\ in\\ disease\\ diagnosis\\ and\\ management\\.\ \(0\)\
\-\ references\ \(24\)\
\-\ \\-\\-\\-\\-\\-\\-\\-\\-\\-\ \(42\)\
\-\ 1\\.\\ agatson\\ as\\.\\ quantification\\ of\\ coronary\\ artery\\ calcification\\ and\\ associated\\ coronary\\ artery\\ disease\\ in\\ asymptomatic\\ young\\ men\\.\\ j\\ am\\ coll\\ cardiol\\.\\ 1992\\;19\\:1167\\-72\\.\ \(0\)\
\-\ 2\\.\\ duerinckx\\ aj\\,\\ higgins\\ cb\\.\\ valvular\\ heart\\ disease\\.\\ radiol\\ clin\\ north\\ am\\.\\ may\\ 1994\\;32\\(3\\)\\:613\\-30\\.\ \(0\)\
\-\ 3\\.\\ janssen\\ s\\,\\ piers\\ da\\,\\ van\\ rijswijk\\ mh\\,\\ meijer\\ s\\,\\ mandema\\ e\\.\\ soft\\ tissue\\ uptake\\ of\\ tc\\-99m\\-diphosphonate\\ and\\ tc\\-99m\\-pyrophosphate\\ in\\ amyloidosis\\.\\ eur\\ j\\ nucl\\ med\\.\\ 1990\\;16\\:663\\â\\€\\“670\\.\ \(0\)\
\-\ 4\\.\\ loutfi\\ i\\,\\ collier\\ bd\\,\\ mohammed\\ am\\.\\ \\ nonosseous\\ abnormalities\\ on\\ bone\\ scans\\.\\ \\ j\\ nuc\\ med\\ tech\\ 2003\\;\\ 31\\:149\\â\\€\\“153\\.\ \(0\)\
\-\ 5\\.\\ silberstein\\ eb\\,\\ francis\\ md\\,\\ tofe\\ aj\\,\\ slough\\ cl\\.\\ distribution\\ of\\ tc\\-99m\\-sn\\ diphosphonate\\ and\\ free\\ tc\\-99m\\ pertechnetate\\ in\\ selected\\ hard\\ and\\ soft\\ tissues\\.\\ \\ j\\ nucl\\ med\\.\\ 1975\\;16\\:58\\â\\€\\“6\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ calcification\\:\\ 0\\.057618308701990015\ \(0\)\
\-\ inferobasilar\\:\\ 0\\.05458525339917337\ \(0\)\
\-\ lv\\:\\ 0\\.04677190171615106\ \(0\)\
\-\ myocardial\\:\\ 0\\.04049535205503397\ \(0\)\
\-\ coronary\\:\\ 0\\.03721505602735315\ \(0\)\
\-\ heart\\:\\ 0\\.03217268969405793\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.030380567304525888\ \(0\)\
\-\ mi\\:\\ 0\\.03024582042247269\ \(0\)\
\-\ cardiac\\:\\ 0\\.025192235239558592\ \(0\)\
\-\ \\;\\:\\ 0\\.025082615336874226\ \(0\)\
\-\ j\\:\\ 0\\.023899017748391566\ \(0\)\
\-\ med\\:\\ 0\\.0227716505504877\ \(0\)\
\-\ deposition\\:\\ 0\\.022163160167795425\ \(0\)\
\-\ nucl\\:\\ 0\\.021745383760800135\ \(0\)\
\-\ infarction\\:\\ 0\\.02162543928686124\ \(0\)\
\-\ aortic\\:\\ 0\\.02141753652813923\ \(0\)\
\-\ aj\\:\\ 0\\.02085472718974199\ \(0\)\
\-\ nuclear\\:\\ 0\\.020474299582208567\ \(0\)\
\-\ am\\:\\ 0\\.020418008434225542\ \(0\)\
\-\ walls\\:\\ 0\\.020253116692165587\ \(0\)\
\-\ valve\\:\\ 0\\.019840047871655546\ \(0\)\
\-\ artery\\:\\ 0\\.019694504582880797\ \(0\)\
\-\ wall\\:\\ 0\\.019157578330021255\ \(0\)\
\-\ medicine\\:\\ 0\\.018823581219049885\ \(0\)\
\-\ valvular\\:\\ 0\\.018521068358855364\ \(0\)\
\-\ scans\\:\\ 0\\.018479426549605358\ \(0\)\
\-\ important\\:\\ 0\\.01782717344371172\ \(0\)\
\-\ bone\\:\\ 0\\.016435252952475773\ \(0\)\
\-\ stenosis\\:\\ 0\\.015545471901693654\ \(0\)\
\-\ may\\:\\ 0\\.014507185517787336\ \(0\)\
\-\ hypokinetic\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ 0\\.9cm2\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ technitium\\-99m\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ 100\\+\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ pack\\-yrs\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ agatson\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ cardiol\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ 19\\:1167\\-72\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ duerinckx\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ \\:613\\-30\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ piers\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ rijswijk\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ meijer\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ mandema\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ tc\\-99m\\-diphosphonate\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ tc\\-99m\\-pyrophosphate\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ 16\\:663\\â\\€\\“670\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ loutfi\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ mohammed\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ 31\\:149\\â\\€\\“153\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ silberstein\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ tofe\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ slough\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ tc\\-99m\\-sn\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ 16\\:58\\â\\€\\“6\\:\\ 0\\.013646313349793342\ \(0\)\
\-\ calcium\\:\\ 0\\.012943620544076974\ \(0\)\
\-\ subendocardial\\:\\ 0\\.01257333009815256\ \(0\)\
\-\ sustain\\:\\ 0\\.01257333009815256\ \(0\)\
\-\ janssen\\:\\ 0\\.01257333009815256\ \(0\)\
\-\ collier\\:\\ 0\\.01257333009815256\ \(0\)\
\-\ nonosseous\\:\\ 0\\.01257333009815256\ \(0\)\
\-\ eb\\:\\ 0\\.01257333009815256\ \(0\)\
\-\ francis\\:\\ 0\\.01257333009815256\ \(0\)\
\-\ \\(\\:\\ 0\\.012300277072263877\ \(0\)\
\-\ \\)\\:\\ 0\\.01215002262112439\ \(0\)\
\-\ as\\:\\ 0\\.012005363831834004\ \(0\)\
\-\ higgins\\:\\ 0\\.01194567513204085\ \(0\)\
\-\ cb\\:\\ 0\\.01194567513204085\ \(0\)\
\-\ tech\\:\\ 0\\.01194567513204085\ \(0\)\
\-\ noticing\\:\\ 0\\.011500346846511777\ \(0\)\
\-\ hypokinesis\\:\\ 0\\.011500346846511777\ \(0\)\
\-\ posterior\\-anterior\\:\\ 0\\.011500346846511777\ \(0\)\
\-\ localizing\\:\\ 0\\.011500346846511777\ \(0\)\
\-\ quantification\\:\\ 0\\.011500346846511777\ \(0\)\
\-\ coll\\:\\ 0\\.011500346846511777\ \(0\)\
\-\ nuc\\:\\ 0\\.011500346846511777\ \(0\)\
\-\ 1975\\:\\ 0\\.011500346846511777\ \(0\)\
\-\ s\\:\\ 0\\.011381273995888175\ \(0\)\
\-\ debated\\:\\ 0\\.011154923392465012\ \(0\)\
\-\ differ\\:\\ 0\\.011154923392465012\ \(0\)\
\-\ related\\:\\ 0\\.010920282951306388\ \(0\)\
\-\ calcifying\\:\\ 0\\.010872691880400067\ \(0\)\
\-\ myocarditis\\:\\ 0\\.010872691880400067\ \(0\)\
\-\ mh\\:\\ 0\\.010872691880400067\ \(0\)\
\-\ bd\\:\\ 0\\.010872691880400067\ \(0\)\
\-\ disease\\:\\ 0\\.01081066208371288\ \(0\)\
\-\ unrevealing\\:\\ 0\\.01063406853701422\ \(0\)\
\-\ persisting\\:\\ 0\\.01063406853701422\ \(0\)\
\-\ bicuspid\\:\\ 0\\.01063406853701422\ \(0\)\
\-\ recognizing\\:\\ 0\\.01063406853701422\ \(0\)\
\-\ implications\\:\\ 0\\.01063406853701422\ \(0\)\
\-\ necrosis\\:\\ 0\\.01044303626453469\ \(0\)\
\-\ circumflex\\:\\ 0\\.010427363594870995\ \(0\)\
\-\ hdp\\:\\ 0\\.010427363594870995\ \(0\)\
\-\ moderate\\:\\ 0\\.010403087642751692\ \(0\)\
\-\ myocardium\\:\\ 0\\.010245036914288358\ \(0\)\
\-\ constrictive\\:\\ 0\\.010245036914288358\ \(0\)\
\-\ eur\\:\\ 0\\.010245036914288358\ \(0\)\
\-\ diphosphonate\\:\\ 0\\.01008194014082423\ \(0\)\
\-\ activity\\:\\ 0\\.009925840955979997\ \(0\)\
\-\ ventricle\\:\\ 0\\.009914521107053957\ \(0\)\
\-\ cad\\:\\ 0\\.009675803508521612\ \(0\)\
\-\ soft\\:\\ 0\\.00966374658201339\ \(0\)\
\-\ pacemaker\\:\\ 0\\.009561085285373437\ \(0\)\
\-\ pertechnetate\\:\\ 0\\.009561085285373437\ \(0\)\
\-\ diastolic\\:\\ 0\\.00945428517471252\ \(0\)\
\-\ wire\\:\\ 0\\.00945428517471252\ \(0\)\
\-\ scapular\\:\\ 0\\.00945428517471252\ \(0\)\
\-\ van\\:\\ 0\\.00945428517471252\ \(0\)\
\-\ summary\\:\\ 0\\.009354380343230212\ \(0\)\
\-\ radiol\\:\\ 0\\.009354380343230212\ \(0\)\
\-\ da\\:\\ 0\\.009354380343230212\ \(0\)\
\-\ radiopharmaceutical\\:\\ 0\\.009260534179427682\ \(0\)\
\-\ location\\:\\ 0\\.009228197173077069\ \(0\)\
\-\ pericarditis\\:\\ 0\\.009172053662647577\ \(0\)\
\-\ 1992\\:\\ 0\\.009172053662647577\ \(0\)\
\-\ attack\\:\\ 0\\.009008956889183448\ \(0\)\
\-\ investigation\\:\\ 0\\.008933430319261726\ \(0\)\
\-\ pericardium\\:\\ 0\\.008933430319261726\ \(0\)\
\-\ 1994\\:\\ 0\\.008933430319261726\ \(0\)\
\-\ cl\\:\\ 0\\.008933430319261726\ \(0\)\
\-\ hypercalcemia\\:\\ 0\\.008861417911158177\ \(0\)\
\-\ 1990\\:\\ 0\\.008861417911158177\ \(0\)\
\-\ \\,\\:\\ 0\\.008800172408456711\ \(0\)\
\-\ north\\:\\ 0\\.00879260713318475\ \(0\)\
\-\ scapula\\:\\ 0\\.008726725377118503\ \(0\)\
\-\ detecting\\:\\ 0\\.008726725377118503\ \(0\)\
\-\ planar\\:\\ 0\\.00860282025688083\ \(0\)\
\-\ correlates\\:\\ 0\\.00860282025688083\ \(0\)\
\-\ occluded\\:\\ 0\\.008544398696535865\ \(0\)\
\-\ hemodynamically\\:\\ 0\\.008544398696535865\ \(0\)\
\-\ amyloid\\:\\ 0\\.008544398696535865\ \(0\)\
\-\ in\\:\\ 0\\.008480130018302343\ \(0\)\
\-\ echocardiography\\:\\ 0\\.008433781105232236\ \(0\)\
\-\ anterolateral\\:\\ 0\\.008433781105232236\ \(0\)\
\-\ unchanged\\:\\ 0\\.008330543683407667\ \(0\)\
\-\ amyloidosis\\:\\ 0\\.00828139709158943\ \(0\)\
\-\ exact\\:\\ 0\\.0081875509277869\ \(0\)\
\-\ mitral\\:\\ 0\\.008099070411006794\ \(0\)\
\-\ severely\\:\\ 0\\.008056657138269774\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.008056657138269774\ \(0\)\
\-\ 78\\:\\ 0\\.008015375022043518\ \(0\)\
\-\ e\\.\\:\\ 0\\.008015375022043518\ \(0\)\
\-\ selected\\:\\ 0\\.008015375022043518\ \(0\)\
\-\ projecting\\:\\ 0\\.007935973637542665\ \(0\)\
\-\ eg\\:\\ 0\\.007935973637542665\ \(0\)\
\-\ modalities\\:\\ 0\\.007935973637542665\ \(0\)\
\-\ seen\\:\\ 0\\.00784192390898308\ \(0\)\
\-\ from\\:\\ 0\\.007841707202193265\ \(0\)\
\-\ echocardiogram\\:\\ 0\\.007824022149029313\ \(0\)\
\-\ metallic\\:\\ 0\\.007824022149029313\ \(0\)\
\-\ variety\\:\\ 0\\.007824022149029313\ \(0\)\
\-\ clin\\:\\ 0\\.007788434659517395\ \(0\)\
\-\ correct\\:\\ 0\\.00775364695696003\ \(0\)\
\-\ repeated\\:\\ 0\\.007653742125477721\ \(0\)\
\-\ curvilinear\\:\\ 0\\.007621823724235095\ \(0\)\
\-\ within\\:\\ 0\\.007570269698387376\ \(0\)\
\-\ tc\\-99m\\:\\ 0\\.00755989596167519\ \(0\)\
\-\ sustained\\:\\ 0\\.0075003506353163735\ \(0\)\
\-\ indicate\\:\\ 0\\.0075003506353163735\ \(0\)\
\-\ exams\\:\\ 0\\.007471415444895084\ \(0\)\
\-\ men\\:\\ 0\\.007471415444895084\ \(0\)\
\-\ contrast\\-enhanced\\:\\ 0\\.007415118782091871\ \(0\)\
\-\ scan\\:\\ 0\\.00740641319019498\ \(0\)\
\-\ left\\:\\ 0\\.007400195582607699\ \(0\)\
\-\ he\\:\\ 0\\.00738138495985455\ \(0\)\
\-\ strongly\\:\\ 0\\.007360797853591454\ \(0\)\
\-\ history\\:\\ 0\\.007307829954842622\ \(0\)\
\-\ example\\:\\ 0\\.00728273151670772\ \(0\)\
\-\ hard\\:\\ 0\\.00728273151670772\ \(0\)\
\-\ severity\\:\\ 0\\.0071844135511932835\ \(0\)\
\-\ processes\\:\\ 0\\.007160779693405685\ \(0\)\
\-\ infarcts\\:\\ 0\\.007114567676146117\ \(0\)\
\-\ pericardial\\:\\ 0\\.007114567676146117\ \(0\)\
\-\ assessment\\:\\ 0\\.007114567676146117\ \(0\)\
\-\ wide\\:\\ 0\\.007091968915432258\ \(0\)\
\-\ tomography\\:\\ 0\\.0070696953280451075\ \(0\)\
\-\ dysfunction\\:\\ 0\\.007047737688738674\ \(0\)\
\-\ accumulation\\:\\ 0\\.007047737688738674\ \(0\)\
\-\ prostate\\:\\ 0\\.007026087159366011\ \(0\)\
\-\ computed\\:\\ 0\\.006983673886628992\ \(0\)\
\-\ mild\\:\\ 0\\.0069667289595391245\ \(0\)\
\-\ generalized\\:\\ 0\\.0069221563500198365\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.006806002811408514\ \(0\)\
\-\ mechanism\\:\\ 0\\.006806002811408514\ \(0\)\
\-\ prior\\:\\ 0\\.006792918799388123\ \(0\)\
\-\ tip\\:\\ 0\\.006787463815980162\ \(0\)\
\-\ smoking\\:\\ 0\\.006680663705319247\ \(0\)\
\-\ 2003\\:\\ 0\\.006646640629903186\ \(0\)\
\-\ develop\\:\\ 0\\.006596968316355972\ \(0\)\
\-\ 32\\:\\ 0\\.006596968316355972\ \(0\)\
\-\ earlier\\:\\ 0\\.006533124727293976\ \(0\)\
\-\ \\/\\:\\ 0\\.006533124727293976\ \(0\)\
\-\ md\\:\\ 0\\.006533124727293976\ \(0\)\
\-\ expected\\:\\ 0\\.006442040361933399\ \(0\)\
\-\ localized\\:\\ 0\\.006442040361933399\ \(0\)\
\-\ place\\:\\ 0\\.006427367383675591\ \(0\)\
\-\ association\\:\\ 0\\.006427367383675591\ \(0\)\
\-\ chest\\:\\ 0\\.006330430340735352\ \(0\)\
\-\ versus\\:\\ 0\\.006287814601950672\ \(0\)\
\-\ tissue\\:\\ 0\\.006270653834218556\ \(0\)\
\-\ associated\\:\\ 0\\.006242918148321059\ \(0\)\
\-\ imaging\\:\\ 0\\.006198370973546758\ \(0\)\
\-\ degree\\:\\ 0\\.006197111561291146\ \(0\)\
\-\ injection\\:\\ 0\\.006172143477808355\ \(0\)\
\-\ ischemia\\:\\ 0\\.0061475717298884016\ \(0\)\
\-\ other\\:\\ 0\\.006097952163165476\ \(0\)\
\-\ demonstrate\\:\\ 0\\.006088087124870095\ \(0\)\
\-\ distribution\\:\\ 0\\.005953103907725229\ \(0\)\
\-\ ventricular\\:\\ 0\\.005910690634988209\ \(0\)\
\-\ exam\\:\\ 0\\.005811869783125505\ \(0\)\
\-\ young\\:\\ 0\\.0057612511194423165\ \(0\)\
\-\ four\\:\\ 0\\.005742372987718139\ \(0\)\
\-\ had\\:\\ 0\\.005708513372262255\ \(0\)\
\-\ 5\\.\\:\\ 0\\.005705293667249884\ \(0\)\
\-\ inflammation\\:\\ 0\\.005624976584635315\ \(0\)\
\-\ mediastinal\\:\\ 0\\.005616304362423751\ \(0\)\
\-\ on\\:\\ 0\\.005602871612735511\ \(0\)\
\-\ increase\\:\\ 0\\.0055486219924333\ \(0\)\
\-\ a\\:\\ 0\\.005525384235862866\ \(0\)\
\-\ amount\\:\\ 0\\.005523985064715189\ \(0\)\
\-\ references\\:\\ 0\\.005499734110002497\ \(0\)\
\-\ i\\:\\ 0\\.005467979404378498\ \(0\)\
\-\ free\\:\\ 0\\.005444583680214337\ \(0\)\
\-\ tissues\\:\\ 0\\.005429180691277544\ \(0\)\
\-\ visualized\\:\\ 0\\.005354384132034808\ \(0\)\
\-\ uptake\\:\\ 0\\.0052553922982882546\ \(0\)\
\-\ aneurysm\\:\\ 0\\.0052282339242156394\ \(0\)\
\-\ 4\\.\\:\\ 0\\.005208173328793805\ \(0\)\
\-\ leg\\:\\ 0\\.005201543821375846\ \(0\)\
\-\ hours\\:\\ 0\\.005201543821375846\ \(0\)\
\-\ failure\\:\\ 0\\.005181823967231218\ \(0\)\
\-\ causes\\:\\ 0\\.005149505724163795\ \(0\)\
\-\ previous\\:\\ 0\\.005136765013426156\ \(0\)\
\-\ the\\:\\ 0\\.00513619633573842\ \(0\)\
\-\ malignancy\\:\\ 0\\.005111593928485319\ \(0\)\
\-\ classic\\:\\ 0\\.005068506004346861\ \(0\)\
\-\ commonly\\:\\ 0\\.004991534742191396\ \(0\)\
\-\ management\\:\\ 0\\.004991534742191396\ \(0\)\
\-\ 8\\:\\ 0\\.004946002412150694\ \(0\)\
\-\ abnormality\\:\\ 0\\.004880120656084446\ \(0\)\
\-\ abnormalities\\:\\ 0\\.0048587687642387255\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.004851437621039901\ \(0\)\
\-\ obtained\\:\\ 0\\.004702579103318641\ \(0\)\
\-\ palpable\\:\\ 0\\.004688267867801534\ \(0\)\
\-\ was\\:\\ 0\\.004589524096967586\ \(0\)\
\-\ 3\\.\\:\\ 0\\.004526121071425275\ \(0\)\
\-\ of\\:\\ 0\\.00450866102159398\ \(0\)\
\-\ cause\\:\\ 0\\.004475638740792517\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.004471505260055863\ \(0\)\
\-\ and\\:\\ 0\\.004458427386556494\ \(0\)\
\-\ recent\\:\\ 0\\.004446933512135909\ \(0\)\
\-\ swelling\\:\\ 0\\.00440682796281909\ \(0\)\
\-\ is\\:\\ 0\\.004352095807931313\ \(0\)\
\-\ cancer\\:\\ 0\\.004348553040812331\ \(0\)\
\-\ finding\\:\\ 0\\.0042632531037747395\ \(0\)\
\-\ revealed\\:\\ 0\\.004245315618987761\ \(0\)\
\-\ radiograph\\:\\ 0\\.004213542807927806\ \(0\)\
\-\ further\\:\\ 0\\.004206569878947768\ \(0\)\
\-\ 2\\.\\:\\ 0\\.004206569878947768\ \(0\)\
\-\ area\\:\\ 0\\.004182409046647473\ \(0\)\
\-\ any\\:\\ 0\\.0041653793081614454\ \(0\)\
\-\ 1\\.\\:\\ 0\\.004131871774454491\ \(0\)\
\-\ approximately\\:\\ 0\\.004092597254730005\ \(0\)\
\-\ severe\\:\\ 0\\.004070139009390099\ \(0\)\
\-\ clinical\\:\\ 0\\.004070139009390099\ \(0\)\
\-\ renal\\:\\ 0\\.0039744203551982495\ \(0\)\
\-\ treated\\:\\ 0\\.00395952141808647\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.003953601764157053\ \(0\)\
\-\ years\\:\\ 0\\.003884277301886196\ \(0\)\
\-\ demonstrated\\:\\ 0\\.003881455081202736\ \(0\)\
\-\ y\\.o\\:\\ 0\\.003817924818245666\ \(0\)\
\-\ abnormal\\:\\ 0\\.0037725886072986245\ \(0\)\
\-\ region\\:\\ 0\\.003736224809967976\ \(0\)\
\-\ include\\:\\ 0\\.0037107639133595774\ \(0\)\
\-\ ct\\:\\ 0\\.0037006305058577185\ \(0\)\
\-\ however\\:\\ 0\\.0036832322842059915\ \(0\)\
\-\ presented\\:\\ 0\\.0036058167724805096\ \(0\)\
\-\ been\\:\\ 0\\.003598753698860668\ \(0\)\
\-\ significant\\:\\ 0\\.00355703893352047\ \(0\)\
\-\ who\\:\\ 0\\.0034488675064113035\ \(0\)\
\-\ patients\\:\\ 0\\.003423490091897873\ \(0\)\
\-\ anterior\\:\\ 0\\.0034068000367844234\ \(0\)\
\-\ for\\:\\ 0\\.0033859511546875313\ \(0\)\
\-\ metastatic\\:\\ 0\\.0033298907176719664\ \(0\)\
\-\ physical\\:\\ 0\\.0032453641943982017\ \(0\)\
\-\ bilateral\\:\\ 0\\.0032102441630254552\ \(0\)\
\-\ noted\\:\\ 0\\.003135326917109278\ \(0\)\
\-\ man\\:\\ 0\\.0031283774660835905\ \(0\)\
\-\ 3\\:\\ 0\\.00309748533545904\ \(0\)\
\-\ \\%\\:\\ 0\\.0030856362745294236\ \(0\)\
\-\ most\\:\\ 0\\.0030539243680001178\ \(0\)\
\-\ posterior\\:\\ 0\\.003048976081582738\ \(0\)\
\-\ diagnosis\\:\\ 0\\.003037491224118297\ \(0\)\
\-\ can\\:\\ 0\\.003000344198868529\ \(0\)\
\-\ well\\:\\ 0\\.002992385376112463\ \(0\)\
\-\ this\\:\\ 0\\.0029756570071644986\ \(0\)\
\-\ case\\:\\ 0\\.0028939697103208526\ \(0\)\
\-\ large\\:\\ 0\\.0028924805446301546\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0028895065041070994\ \(0\)\
\-\ have\\:\\ 0\\.0028644552296673248\ \(0\)\
\-\ 2\\:\\ 0\\.002848458972926542\ \(0\)\
\-\ after\\:\\ 0\\.0027368439668873103\ \(0\)\
\-\ patient\\:\\ 0\\.0026519874022179197\ \(0\)\
\-\ also\\:\\ 0\\.0026077702688392435\ \(0\)\
\-\ images\\:\\ 0\\.002537560204255966\ \(0\)\
\-\ has\\:\\ 0\\.0024840556818796875\ \(0\)\
\-\ that\\:\\ 0\\.0022847998894099434\ \(0\)\
\-\ \\.\\:\\ 0\\.0020882080057262513\ \(0\)\
\-\ be\\:\\ 0\\.0020398710887676924\ \(0\)\
\-\ to\\:\\ 0\\.001983288429301794\ \(0\)\
\-\ mass\\:\\ 0\\.0018397229209714623\ \(0\)\
\-\ an\\:\\ 0\\.0018292025762921516\ \(0\)\
\-\ with\\:\\ 0\\.001630089140571219\ \(0\)\
\-\ pain\\:\\ 0\\.0016154925193974223\ \(0\)\
\-\ or\\:\\ 0\\.0015503448126373183\ \(0\)\
\-\ right\\:\\ 0\\.0013957147199851652\ \(0\)\
\-\ no\\:\\ 0\\.0013319568896343684\ \(0\)\
